Cargando…
Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides
Oligonucleotide analogs have provided novel therapeutics targeting various disorders. However, their poor cellular uptake remains a major obstacle for their clinical development. Negatively charged oligonucleotides, such as 2′-O-Methyl RNA and locked nucleic acids have in recent years been delivered...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376484/ https://www.ncbi.nlm.nih.gov/pubmed/25594433 http://dx.doi.org/10.1089/nat.2014.0511 |
_version_ | 1782363743398658048 |
---|---|
author | Järver, Peter Zaghloul, Eman M. Arzumanov, Andrey A. Saleh, Amer F. McClorey, Graham Hammond, Suzan M. Hällbrink, Mattias Langel, Ülo Smith, C.I. Edvard Wood, Matthew J.A. Gait, Michael J. EL Andaloussi, Samir |
author_facet | Järver, Peter Zaghloul, Eman M. Arzumanov, Andrey A. Saleh, Amer F. McClorey, Graham Hammond, Suzan M. Hällbrink, Mattias Langel, Ülo Smith, C.I. Edvard Wood, Matthew J.A. Gait, Michael J. EL Andaloussi, Samir |
author_sort | Järver, Peter |
collection | PubMed |
description | Oligonucleotide analogs have provided novel therapeutics targeting various disorders. However, their poor cellular uptake remains a major obstacle for their clinical development. Negatively charged oligonucleotides, such as 2′-O-Methyl RNA and locked nucleic acids have in recent years been delivered successfully into cells through complex formation with cationic polymers, peptides, liposomes, or similar nanoparticle delivery systems. However, due to the lack of electrostatic interactions, this promising delivery method has been unsuccessful to date using charge-neutral oligonucleotide analogs. We show here that lipid-functionalized cell-penetrating peptides can be efficiently exploited for cellular transfection of the charge-neutral oligonucleotide analog phosphorodiamidate morpholino. The lipopeptides form complexes with splice-switching phosphorodiamidate morpholino oligonucleotide and can be delivered into clinically relevant cell lines that are otherwise difficult to transfect while retaining biological activity. To our knowledge, this is the first study to show delivery through complex formation of biologically active charge-neutral oligonucleotides by cationic peptides. |
format | Online Article Text |
id | pubmed-4376484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-43764842015-05-13 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides Järver, Peter Zaghloul, Eman M. Arzumanov, Andrey A. Saleh, Amer F. McClorey, Graham Hammond, Suzan M. Hällbrink, Mattias Langel, Ülo Smith, C.I. Edvard Wood, Matthew J.A. Gait, Michael J. EL Andaloussi, Samir Nucleic Acid Ther Original Articles Oligonucleotide analogs have provided novel therapeutics targeting various disorders. However, their poor cellular uptake remains a major obstacle for their clinical development. Negatively charged oligonucleotides, such as 2′-O-Methyl RNA and locked nucleic acids have in recent years been delivered successfully into cells through complex formation with cationic polymers, peptides, liposomes, or similar nanoparticle delivery systems. However, due to the lack of electrostatic interactions, this promising delivery method has been unsuccessful to date using charge-neutral oligonucleotide analogs. We show here that lipid-functionalized cell-penetrating peptides can be efficiently exploited for cellular transfection of the charge-neutral oligonucleotide analog phosphorodiamidate morpholino. The lipopeptides form complexes with splice-switching phosphorodiamidate morpholino oligonucleotide and can be delivered into clinically relevant cell lines that are otherwise difficult to transfect while retaining biological activity. To our knowledge, this is the first study to show delivery through complex formation of biologically active charge-neutral oligonucleotides by cationic peptides. Mary Ann Liebert, Inc. 2015-04-01 /pmc/articles/PMC4376484/ /pubmed/25594433 http://dx.doi.org/10.1089/nat.2014.0511 Text en © Peter Jäver et al. 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Original Articles Järver, Peter Zaghloul, Eman M. Arzumanov, Andrey A. Saleh, Amer F. McClorey, Graham Hammond, Suzan M. Hällbrink, Mattias Langel, Ülo Smith, C.I. Edvard Wood, Matthew J.A. Gait, Michael J. EL Andaloussi, Samir Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides |
title | Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides |
title_full | Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides |
title_fullStr | Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides |
title_full_unstemmed | Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides |
title_short | Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides |
title_sort | peptide nanoparticle delivery of charge-neutral splice-switching morpholino oligonucleotides |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376484/ https://www.ncbi.nlm.nih.gov/pubmed/25594433 http://dx.doi.org/10.1089/nat.2014.0511 |
work_keys_str_mv | AT jarverpeter peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT zaghloulemanm peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT arzumanovandreya peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT salehamerf peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT mccloreygraham peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT hammondsuzanm peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT hallbrinkmattias peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT langelulo peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT smithciedvard peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT woodmatthewja peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT gaitmichaelj peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides AT elandaloussisamir peptidenanoparticledeliveryofchargeneutralspliceswitchingmorpholinooligonucleotides |